47 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
Governance Committee
CORPORATE GOVERNANCE HIGHLIGHTS
The following table summarizes our current Board structure and key elements of our corporate … NOMINEES
CONTINUING DIRECTORS
CORPORATE GOVERNANCE AND RISK MANAGEMENT
BOARD INDEPENDENCE
BOARD LEADERSHIP STRUCTURE
BOARD COMMITTEES
RISK MANAGEMENT
8-K
LRMR
Larimar Therapeutics Inc
3 Oct 23
Departure of Directors or Certain Officers
4:31pm
of the Nominating and Corporate Governance Committee, appointed Jeffrey W. Sherman, MD, FACP to serve as a Class I director, with an initial term expiring … at the Company’s 2024 Annual Meeting of Stockholders, and a member of the Nominating and Corporate Governance Committee.
Dr. Sherman, 68, has served
8-K/A
EX-99.2
u5yn98 o83ir
26 Jun 20
Other Events
5:08pm
8-K
EX-14.1
jdgv ce4u82am8vxt3p
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
qbdkitan71bbvmxmp7s
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFM14A
7akye4bl8a3v
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
s5o kv0z9c
10 Apr 20
Preliminary revised proxy
4:38pm
PREM14A
se6qhj kr
6 Mar 20
Preliminary proxy related to merger
5:32pm